The successful candidate will initiate, implement, and complete the quantitative methodology aspects of numerous major clinical programs whose objectives are to create scientific information that will be valuable for appropriate clinical use and substantiation of value of Operating Company (OpCo) products: In addition, they will develop protocols for Phase 3, 3b, and 4 trials by working with the clinical trials groups within Medical Affairs (MA) on study design, including the critical statistical components of these trials, and by writing the statistical procedures sections.